These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12657615)

  • 1. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.
    Rakic JM; Lambert V; Munaut C; Bajou K; Peyrollier K; Alvarez-Gonzalez ML; Carmeliet P; Foidart JM; Noël A
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1732-9. PubMed ID: 12657615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model.
    Das A; Boyd N; Jones TR; Talarico N; McGuire PG
    Arch Ophthalmol; 2004 Dec; 122(12):1844-9. PubMed ID: 15596589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
    Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
    Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
    Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
    Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.
    Siconolfi LB; Seeds NW
    J Neurosci; 2001 Jun; 21(12):4348-55. PubMed ID: 11404420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
    McGuire PG; Jones TR; Talarico N; Warren E; Das A
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
    Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
    Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis.
    Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W
    FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials.
    Lambert V; Munaut C; Carmeliet P; Gerard RD; Declerck PJ; Gils A; Claes C; Foidart JM; Noël A; Rakic JM
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2791-7. PubMed ID: 12766088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of plasminogen activator and inhibitor, urokinase receptor and inhibin subunits in rhesus monkey testes.
    Zhang T; Zhou HM; Liu YX
    Mol Hum Reprod; 1997 Mar; 3(3):223-31. PubMed ID: 9237248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.
    Piguet PF; Da Laperrousaz C; Vesin C; Tacchini-Cottier F; Senaldi G; Grau GE
    Infect Immun; 2000 Jul; 68(7):3822-9. PubMed ID: 10858190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.
    Ahn MY; Zhang ZG; Tsang W; Chopp M
    Brain Res; 1999 Aug; 837(1-2):169-76. PubMed ID: 10433999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the urokinase-type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis.
    Herouy Y; Aizpurua J; Stetter C; Dichmann S; Idzko M; Hofmann C; Gitsch G; Vanscheidt W; Schöpf E; Norgauer J
    J Cutan Pathol; 2001 Jul; 28(6):291-7. PubMed ID: 11401675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
    Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen Activators and Inhibitors in the Corneas of Mice Infected with Pseudomonas aeruginosa.
    Berk RS; Katar M; Dong Z; Day DE
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1561-7. PubMed ID: 11381061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
    Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
    Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
    Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.